The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
抗糖尿病药物PPARγ激动剂吡格列酮可抑制前列腺癌细胞增殖并诱导代谢重编程。
期刊:Molecular Cancer
影响因子:27.7
doi:10.1186/s12943-025-02320-y
Emine Atas ,Kerstin Berchtold ,Michaela Schlederer ,Sophie Prodinger ,Felix Sternberg ,Perla Pucci ,Christopher Steel ,Jamie D Matthews ,Emily R James ,Cécile Philippe ,Karolína Trachtová ,Ali A Moazzami ,Nastasiia Artamonova ,Felix Melchior ,Torben Redmer ,Gerald Timelthaler ,Elena E Pohl ,Suzanne D Turner ,Isabel Heidegger ,Marcus Krueger ,Ulrike Resch ,Lukas Kenner
前列腺癌
细胞生物学
肿瘤
代谢重编程
糖尿病
肿瘤免疫
代谢
